Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2001-09-06
2008-08-12
Andres, Janet L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S405000, C549S407000, C549S408000
Reexamination Certificate
active
07410998
ABSTRACT:
Benzopyran-based inhibitors of NADH:ubiquinone oxidoreductase for inhibiting the growth of cancer cells.
REFERENCES:
Kumar, J. K. et al ‘Further dihydrochalcones fromCrotolaria ramosissima’ CA 132:105317 (1999).
Nicolaou K.C. et al ‘Natural Product-like Combinatorial Libraries Based on Privileged Structures. 3. The “Libraries from Libraries” Principle for Diversity Enhancement ofBenzopyran Libraries’ CA 134:17372 (2000).
Jain, AC et al ‘Synthesis of erthrinin-A and related isoflavones’ CA 104:5664 (1986).
Nicolaou et al Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase CA 134:260863 (2001).
Nicolaou et al Natural product-like combinatorial libraries based on privileged structures. 3. the libraries from libraries principle for diversity enhancement of benzopyran libraries CA 134:17372 (2000.
Kumar et al Further dihyrochalcones fromCrotolaria ramosissimaA 132:105317 (1999).
Villain et al An easy synthesis of angular 6″,6″-dimethylpyanoisoflavones CA 87:39333 (1977).
Adityachaudhury et al Synthesis of tetrahydroflemichapparin A CA 82:170595 (1975).
Jain et al Nuclear prenylation of 2,4-dihydroxyphenylbenzyl ketone. Synthesis of linear and angular 6″,6″-dimethylpyranoisoflavones, and their 2-methyl and 2-phenyl analogs CA 76:99452 (1972).
Zelinski et al Acetylenic reactions of 2-(phenylethynyl)tetrahydropyran CA 53:7016 (1959).
Hashimoto, et al CA 117:69734 (1992).
Tanaka, et al CA 106:47187 (1987).
Nicolaou et al CA 134:260863 (2001).
Hashimoto CA 117:48593.
Earley, et al., “Photolabelling of a mitochondrially encoded subunit of NADH dehydrogenase with [3H]dihydrorotenone”,FEBS Lett. 219: 108-113 (1987).
Crombie, et al., “The Rotenoid Core Structure: Modifications to Define the Requirements of the Toxophore”,Bioorg. Med. Chem. Lett. 2: 13-16 (1992).
Levett, et al., “Structural Requirements for Respiratory Inhibition by Rotenoids: Is an Intact B/C Ring System Essential?”,Bioorg. Med. Chem. Lett. 4: 505-508 (1994).
Gerhäuser, et al., “Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase”,Nature Med. 1: 260-266 (1995).
Ding, C. Z., “A Convenient Synthesis of 6-Substituted-2,2-dimethyl-2H-1-Benzopyrans”,Syn. Commun. 26: 4267-4273 (1996).
Udeani, et al., “Cancer Chemopreventive Activity Mediated by Deguelin, a Naturally Occurring Rotenoid”,Cancer Res. 57: 3424-3428 (1997).
Gerhäuser, et al., “Regulation of Ornithine Decarboxylase Induction by Deguelin, a Natural Product Cancer Chemopreventive Agent”,Cancer Res. 57: 3429-3435 (1997).
Fang, et al., “Anomalous Structure-Activity Relationships of 13-homo-13-Oxarotenoids and 13-homo-13-Oxadehydrorotenoids”,Chem. Res. Toxicol. 10: 853-858 (1997).
Nicolaou, et al., “Polymer-supported selenium reagents for organic synthesis”,Chem. Commun.:1947-1948 (1998).
Fang, et al., “Anticancer action of cubé insecticide: Correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities”,Proc. Natl. Acad. Sci. USA 95:3380-3384 (1998).
Esposti, M. D., “Inhibitors of NADH-ubiquinone reductase: an overview”,Biochim. Biophys. Acta 1364:222-235 (1998).
Lümmen, P., “Complex I inhibitors as insecticides and acaricides”,Biochim. Biophys. Acta 1364:287-296 (1998).
Fang, et al., “New Bioactive Flavonoids and Stilbenes in Cubé Resin Insecticide”,J. Nat. Prod. 62:205-210 (1999).
Barrientos, et al., “Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology”,J. Biol. Chem. 274:16188-16197 (1999).
Nicolaou, et al., “Selenium-Based Solid-Phase Synthesis of Benzopyrans I: Application to Combinatorial Synthesis of Natural Products”,Angew. Chem. Int. Ed. 39:734-739 (2000).
Nicolaou, et al., “Selenium-Based Solid-Phase Synthesis of Benzopyrans II: Applications to Combinatorial Synthesis of Medicinally Relevant Small Organic Molecules”,Angew. Chem. Int. Ed. 39:739-743 (2000).
Nicolaou, et al., “Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid Phase Synthesis of Benzopyrans”,J. Am. Chem. Soc. 122:9939-9953 (2000).
Nicolaou, et al., “Natural Product-like Combinatorial Libraries Based on Privileged Structures. 2. Construction of a 10000-Membered Benzopyran Library by Direct Split-and-Pool Chemistry Using NanoKans and Optical Encoding”,J. Am. Chem. Soc. 122:9954-9967 (2000).
Nicolaou, et al., “Natural Product-like Combinatorial Libraries Based on Privileged Structures. 3. The “Libraries from Libraries” Principle for Diversity Enhancement of Benzopyran Libraries”,J. Am. Chem. Soc. 122:9968-9976 (2000).
Hashimoto, et al., “Preparation of benzopyran derivatives having antihypertensive and vasodilatory activity”, Database Registry File on STN (Columbus, OH, USA), No. 117:69734, abstract, (see compound with RN 142314-64-5, 1992.
Hashimoto, et al., “Preparation of benzopyran derivatives as cardiovascular agents”, Database Registry File on STN (Columbus, OH, USA), No. 117:48593, abstract, (see compound with RN 139081-48-4, 1991.
Tanaka, et al., “Chemical and chemotaxonomic studis of pterophytens. Chemical studies on the constituents ofSceptridium ternatumvar.ternatum”, Database Registry File on STN (Columbus, OH, USA), No. 106:47187, abstract, (see compound with RN 106235-42-1, 1986.
Cao Guo-Qiang
Nicolaou Kyriacos C.
Pfefferkorn Jeffrey
Roecker Anthony
Andres Janet L.
Covington Raymond
Fitting Thomas
Lewis Donald G.
The Scripps Research Institute
LandOfFree
Inhibitors of NADH:ubiquinone oxidoreductase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of NADH:ubiquinone oxidoreductase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of NADH:ubiquinone oxidoreductase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997636